drugset / Trial / NCT02553187
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Phase 4
Unknown
160 enrolled
Zhejiang Kanglaite Pharmaceutical Co.Ltd
H & J CRO International, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to explore the efficacy and safety of Kanglaite Injection in the treatment of patients with late-stage cancer cachexia.
Timeline
- Start
- 2015-09
- Primary completion
- 2017-07
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kanglaite | Traditional medicine (herbal / TCM) | 200 ml | Intravenous |
Indications
No indication recorded.